Related Experiment Videos
Stabilisation splint therapy for temporomandibular pain dysfunction syndrome.
M Z Al-Ani1, S J Davies, R J M Gray
1TMD Unit, Prosthodontics, University Dental Hospital of Manchester, Higher Cambridge Street, Manchester, UK, M15 6FH.
The Cochrane Database of Systematic Reviews
|February 20, 2004
Summary
Stabilisation splint therapy shows weak evidence for reducing pain in temporomandibular pain dysfunction syndrome (PDS) compared to no treatment. However, current evidence is insufficient to support its use over other active treatments for PDS.
Area of Science:
- Oral Medicine
- Dental Research
- Pain Management
Background:
- Pain Dysfunction Syndrome (PDS) is the most prevalent temporomandibular disorder (TMD).
- PDS presents with various synonyms, including facial arthromyalgia and myofascial pain dysfunction.
- The etiology of PDS is multifactorial, with diverse therapeutic approaches advocated.
Purpose of the Study:
- To evaluate the efficacy of stabilisation splint therapy in alleviating symptoms for patients diagnosed with PDS.
- To compare stabilisation splint therapy against placebo, alternative treatments, and no treatment interventions.
Main Methods:
- A systematic review of randomized or quasi-randomized controlled trials (RCTs) was conducted.
- Searches included major electronic databases and handsearching of journals, with no language restrictions.
- Data extraction and validity assessment were performed independently by two reviewers.
Main Results:
- Twelve RCTs were analyzed, comparing stabilisation splint therapy (SS) with acupuncture, bite plates, biofeedback, relaxation, jaw exercises, and no treatment.
- No statistically significant difference was found between SS and other active treatments for PDS symptom reduction.
- Weak evidence suggests SS may reduce pain severity compared to no treatment.
Conclusions:
- Insufficient evidence exists to definitively support or refute the use of SS for PDS.
- Further high-quality RCTs are recommended, focusing on methodological rigor and standardized outcome measures.
- Standardization of outcome assessment in PDS treatment trials is crucial for future research.